EGFR and bone metastasis: Baseline characteristics of Stage IV lung adenocarcinomas underwent EGFR‐TKIs plus brain metastasis radiotherapy (N = 98) or bone metastasis radiotherapy (N = 85) between exon 19‐Del and 21‐L858R.